Vorasidenib approved in Scotland – people living with grade 2 brain tumours in England must not be left behind.
Scotland’s medicines regulator has approved the first targeted therapy for low grade brain tumours in a generation. brainstrust calls on England to address the inequity of access to Vorasidenib. [...]
